EP on EP Episode 89: Hypertrophic Cardiomyopathy and SCD with Martin Maron, MD-In this episode, Eric N. Prystowsky, MD, FHRS, and Martin Maron, MD, discuss Hypertrophic Cardiomyopathy and SCD with Martin Maron, MD

In this episode, Eric N. Prystowsky, MD, FHRS, and Martin Maron, MD, discuss Hypertrophic Cardiomyopathy and SCD with Martin Maron, MD

Back to course

Video Transcription

Video Summary

In this video summary, experts discuss a new energy source called pulse field ablation (PFA). PFA is a non-thermal energy that uses high-voltage, short-duration electrical fields to create a transmural lesion. The experts explain that PFA can be used as an alternative to radiofrequency (RF) ablation for treating arrhythmias, such as atrial fibrillation. They note that PFA has several advantages over RF ablation, including shorter procedure times, improved lesion durability, and a lower risk of collateral tissue damage. The experts also discuss the use of various catheters and waveforms in PFA, noting that different devices may have different efficacy and safety profiles. They emphasize the importance of good catheter-tissue contact for optimal lesion formation and mention the potential role of imaging techniques in guiding PFA procedures. The panelists also address concerns about coronary spasm as a potential side effect of PFA and explain that more research is needed to fully understand and manage this issue. Overall, the experts are optimistic about the future of PFA and believe it has the potential to significantly improve the safety and efficacy of ablation procedures for cardiac arrhythmias.

Keywords

pulse field ablation

energy source

non-thermal energy

high-voltage

short-duration electrical fields

transmural lesion

radiofrequency ablation

arrhythmias

atrial fibrillation

procedure times

lesion durability

collateral tissue damage

catheters

waveforms

efficacy